Global Leukapheresis Market, 2021-2027

October 2021 | 81 pages | ID: G36671977FA5EN
Gen Consulting Company

Abstracts

Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is the first step in a treatment called CAR (chimeric antigen receptor) T-cell therapy. The global leukapheresis market is expected to increase by USD 61 million, at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2027, according to the latest edition of the Global Leukapheresis Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global leukapheresis market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The leukapheresis market is segmented on the basis of product, application, end user, and region. The leukapheresis market is segmented as below:

By product:

• leukapheresis devices
• leukapheresis disposables

By application:

• research
• therapies

By end user:

• blood centers
• hospitals & infusion centers
• enterprises
• academic & research institutes

By region:

• region
• Asia Pacific
• Europe
• North America
• Middle East and Africa (MEA)
• South America

The report also provides analysis of the key companies of the industry and their detailed company profiles including AllCells Corporation, Asahi Kasei Corporation, BioIVT LLC, Fresenius SE & Co. KGaA, Haemonetics Corporation, HemaCare Corporation (Charles River Laboratories International, Inc.), Macopharma, STEMCELL Technologies Inc., StemExpress, LLC, Terumo Corporation, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global leukapheresis market.
• To classify and forecast the global leukapheresis market based on product, application, end user, and region.
• To identify drivers and challenges for the global leukapheresis market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global leukapheresis market.
• To identify and analyze the profile of leading players operating in the global leukapheresis market.

Why Choose This Report

• Gain a reliable outlook of the global leukapheresis market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR LEUKAPHERESIS BY PRODUCT

5.1 Leukapheresis devices
  5.1.1 Market size and forecast
5.2 Leukapheresis disposables
  5.2.1 Market size and forecast

PART 6. GLOBAL MARKET FOR LEUKAPHERESIS BY APPLICATION

6.1 Research
  6.1.1 Market size and forecast
6.2 Therapies
  6.2.1 Market size and forecast

PART 7. GLOBAL MARKET FOR LEUKAPHERESIS BY END USER

7.1 Blood centers
  7.1.1 Market size and forecast
7.2 Hospitals & infusion centers
  7.2.1 Market size and forecast
7.3 Enterprises
  7.3.1 Market size and forecast
7.4 Academic & research institutes
  7.4.1 Market size and forecast

PART 8. GLOBAL MARKET FOR LEUKAPHERESIS BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Middle East and Africa (MEA)
  8.4.1 Market size and forecast
8.5 South America
  8.5.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 AllCells Corporation
9.2 Asahi Kasei Corporation
9.3 BioIVT LLC
9.4 Fresenius SE & Co. KGaA
9.5 Haemonetics Corporation
9.6 HemaCare Corporation (Charles River Laboratories International, Inc.)
9.7 Macopharma
9.8 STEMCELL Technologies Inc.
9.9 StemExpress, LLC
9.10 Terumo Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY